Enhanced Techniques of NMIBC Detection
Dr. Mark D. Tyson, II, MD, MPH, moderates this session by discussing the critical need for precise detection techniques in managing NMIBC.
Read MoreSelect Page
Mark D. Tyson II, MD, MPH, is a urologic oncologist and Associate Professor of Urology with the Mayo Clinic Alix School of Medicine in Scottsdale, Arizona. Dr. Tyson completed his medical education at Dartmouth Medical School and holds a Masters in Public Health, with an emphasis in Epidemiology and Biostatistics, from the Harvard T. H. Chan School of Public Health. He completed a urology and surgical residency at the Mayo School of Graduate Medical Education at the Mayo Clinic College of Medicine, going on to complete a fellowship in urologic oncology from the Vanderbilt University School of Medicine. His clinical focus includes treatments for bladder cancer, including single port radical cystectomy with urinary diversion. Dr. Tyson is active in research and education, providing mentorship to trainees. He authors expert content and publishes regularly in scientific journals.
Disclosures:Posted by Mark Tyson II, MD, MPH | Dec 2022
Dr. Mark D. Tyson, II, MD, MPH, moderates this session by discussing the critical need for precise detection techniques in managing NMIBC.
Read More